Presence of Salmonella spp. in one-day-old chicks from hatcheries in the metropolitan region of Fortaleza, Brazil

Background: Salmonellosis is caused by bacteria of the genus Salmonella and is a worldwide-considered major zoonosis with arisk for the public health due to the capacity of dissemination between animals and nature. In the poultry industry, day-old chicksmay acquire the infection at the hatchery through contact with fomites and eggshells with the presence of contaminated feces,favoring the animal infection and may become a source of infection to other birds in the lot, as well as to several other animals,including man. The aim of this study was to verify the presence of Salmonella spp. in one-day-old chicks from hatcheries in themetropolitan region of Fortaleza, Brazil.Materials, Methods & Results: A transversal study with a convenience sampling was performed in 510 day-old chicks acquiredfrom five hatcheries located in the metropolitan region of Fortaleza, Brazil. From each hatchery, 102 day-old chicks were analyzed at the Laboratory of Ornithological Studies (LABEO) of the State University of Ceará. Individual cloacal swab sampleswere collected immediately after arrival, following euthanasia by cervical dislocation for organ sampling, comprised of a poolof livers and yolk sacs of three birds per sample. Organ and cloacal samples were incubated in pre-enrichment using bufferedpeptone water 0.1%, following selective enrichment with the broths: Tetrathionate, Rappaport-Vassiliadis and Selenite-Cystine.After incubation, samples were streaked in Brilliant Green agar added Novobiocin (40 µg/mL) and MacConkey agar. For all themicrobiological procedures, samples were incubated at 35 to 37°C for 18 to 24 h. Suspect colonies were identified by biochemical tests and confirmed with polyvalent O anti-Salmonella serum. Salmonella isolates were submitted to disk-diffusion method(Kirby-Bauer) following the National Committee for Clinical Laboratory Standards (NCCLS) guidelines. With the...(AU)

Presence of Salmonella spp. in one-day-old chicks from hatcheries in the metropolitan region of Fortaleza, Brazil

Background: Salmonellosis is caused by bacteria of the genus Salmonella and is a worldwide-considered major zoonosis with arisk for the public health due to the capacity of dissemination between animals and nature. In the poultry industry, day-old chicksmay acquire the infection at the hatchery through contact with fomites and eggshells with the presence of contaminated feces,favoring the animal infection and may become a source of infection to other birds in the lot, as well as to several other animals,including man. The aim of this study was to verify the presence of Salmonella spp. in one-day-old chicks from hatcheries in themetropolitan region of Fortaleza, Brazil.Materials, Methods & Results: A transversal study with a convenience sampling was performed in 510 day-old chicks acquiredfrom five hatcheries located in the metropolitan region of Fortaleza, Brazil. From each hatchery, 102 day-old chicks were analyzed at the Laboratory of Ornithological Studies (LABEO) of the State University of Ceará. Individual cloacal swab sampleswere collected immediately after arrival, following euthanasia by cervical dislocation for organ sampling, comprised of a poolof livers and yolk sacs of three birds per sample. Organ and cloacal samples were incubated in pre-enrichment using bufferedpeptone water 0.1%, following selective enrichment with the broths: Tetrathionate, Rappaport-Vassiliadis and Selenite-Cystine.After incubation, samples were streaked in Brilliant Green agar added Novobiocin (40 µg/mL) and MacConkey agar. For all themicrobiological procedures, samples were incubated at 35 to 37°C for 18 to 24 h. Suspect colonies were identified by biochemical tests and confirmed with polyvalent O anti-Salmonella serum. Salmonella isolates were submitted to disk-diffusion method(Kirby-Bauer) following the National Committee for Clinical Laboratory Standards (NCCLS) guidelines. With the...

Azitromicina no tratamento da erlichiose monocítica em cães naturalmente infectados / Azithromycin in the treatment of monocytic ehrlichiosis in naturally infected dogs

The aims of this study were to evaluate the effectiveness of treatment with azithromycin in dogs naturally infected with E. canis, and to analyse the clinical and hematological changes the animals would show. Ten dogs with positive diagnosis for E. canis through Elisa Snap 4Dx test were distributed into two groups, untreated and treated with azithromycin, 20 mg/kg, orally once a day for seven days. In addition to the physical exam, complete blood counts (CBC), smears made out from blood of the ear margin in order to detect ehrlichial morulae and nested PCR before treatment and post-treatment were performed. We found that the treatment was not effective, since the clinical signs did not disappear, as well as there was no return to normal values of the CBC in treated animas, neither the elimination of E. canis from the infected animals.

Os objetivos deste trabalho foram avaliar a eficácia do tratamento com azitromicina em cães naturalmente infectados por E. canis e acompanhar a evolução clínico-hematológica dos animais. Dez cães, com diagnóstico positivo para E. canis por meio do teste de Elisa Snap 4Dx, foram distribuídos em dois grupos, sem tratamento e tratados com azitromicina, 20 mg/kg, via oral, uma vez ao dia, durante sete dias. Além do exame físico diário foram realizados hemogramas, esfregaços de ponta de orelha para a pesquisa de mórulas e nested PCR antes do tratamento e pós-tratamento. Verificou-se que o tratamento não foi eficiente, uma vez que não desapareceram os sinais clínicos, assim como não houve retorno à normalidade dos valores do hemograma nos cães, assim como ausência de eliminação de E. canis.

Azitromicina no tratamento da erlichiose monocítica em cães naturalmente infectados

The aims of this study were to evaluate the effectiveness of treatment with azithromycin in dogs naturally infected with E. canis, and to analyse the clinical and hematological changes the animals would show. Ten dogs with positive diagnosis for E. canis through Elisa Snap 4Dx test were distributed into two groups, untreated and treated with azithromycin, 20 mg/kg, orally once a day for seven days. In addition to the physical exam, complete blood counts (CBC), smears made out from blood of the ear margin in order to detect ehrlichial morulae and nested PCR before treatment and post-treatment were performed. We found that the treatment was not effective, since the clinical signs did not disappear, as well as there was no return to normal values of the CBC in treated animas, neither the elimination of E. canis from the infected animals.

Os objetivos deste trabalho foram avaliar a eficácia do tratamento com azitromicina em cães naturalmente infectados por E. canis e acompanhar a evolução clínico-hematológica dos animais. Dez cães, com diagnóstico positivo para E. canis por meio do teste de Elisa Snap 4Dx, foram distribuídos em dois grupos, sem tratamento e tratados com azitromicina, 20 mg/kg, via oral, uma vez ao dia, durante sete dias. Além do exame físico diário foram realizados hemogramas, esfregaços de ponta de orelha para a pesquisa de mórulas e nested PCR antes do tratamento e pós-tratamento. Verificou-se que o tratamento não foi eficiente, uma vez que não desapareceram os sinais clínicos, assim como não houve retorno à normalidade dos valores do hemograma nos cães, assim como ausência de eliminação de E. canis.

Azitromicina no tratamento da erlichiose monocítica em cães naturalmente infectados / Azithromycin in the treatment of monocytic ehrlichiosis in naturally infected dogs

The aims of this study were to evaluate the effectiveness of treatment with azithromycin in dogs naturally infected with E. canis, and to analyse the clinical and hematological changes the animals would show. Ten dogs with positive diagnosis for E. canis through Elisa Snap 4Dx test were distributed into two groups, untreated and treated with azithromycin, 20 mg/kg, orally once a day for seven days. In addition to the physical exam, complete blood counts (CBC), smears made out from blood of the ear margin in order to detect ehrlichial morulae and nested PCR before treatment and post-treatment were performed. We found that the treatment was not effective, since the clinical signs did not disappear, as well as there was no return to normal values of the CBC in treated animas, neither the elimination of E. canis from the infected animals.(AU)

Os objetivos deste trabalho foram avaliar a eficácia do tratamento com azitromicina em cães naturalmente infectados por E. canis e acompanhar a evolução clínico-hematológica dos animais. Dez cães, com diagnóstico positivo para E. canis por meio do teste de Elisa Snap 4Dx, foram distribuídos em dois grupos, sem tratamento e tratados com azitromicina, 20 mg/kg, via oral, uma vez ao dia, durante sete dias. Além do exame físico diário foram realizados hemogramas, esfregaços de ponta de orelha para a pesquisa de mórulas e nested PCR antes do tratamento e pós-tratamento. Verificou-se que o tratamento não foi eficiente, uma vez que não desapareceram os sinais clínicos, assim como não houve retorno à normalidade dos valores do hemograma nos cães, assim como ausência de eliminação de E. canis.(AU)

Suscetibilidade à azitromicina de agentes bacterianos isolados de processos infecciosos em diferentes sítios de animais de companhia / Azithromycin susceptibility pattern of bacterial isolated from different sites of infections in pet animals

Avaliou-se o perfil de suscetibilidade bacteriana de diferentes sítios infecciosos frente aos antimicrobianos de eleição e determinaram-se o perfil de atividade in vitro e a concentração inibitória mínima (CIM) da azitromicina. Diferentes testes fenotípicos detectaram resistência à azitromicina em 45 por cento de Staphylococcus spp. e 65 por cento dos bastonetes Gram-negativo. A CIM50 para S. aureus foi 4,0μg/mL para S. intermedius 1,0μg/mL, Staphylococcus spp. coagulase-negativo >512μg/mL e bastonetes Gram-negativo 256μg/mL. Investigou-se, também, uma possível resistência cruzada entre oxacilina e azitromicina por meio da detecção do gene mecA em Staphylococcus spp. Foi possível detectar resistência à azitromicina em nove (15 por cento) isolados de Staphylococcus spp. mecA positivo.(AU)

Antimicrobials susceptibility pattern of bacterial isolated from different sites of infection, in vitro azithromycin activity pattern, and its minimum inhibitory concentration (MIC) values were evaluated. Different phenotypic tests detected azithromycin resistance in 45 percent of Staphylococcus spp. and 65 percent of resistant Gram-negative rods. MIC50 was 4.0μg/mL for Staphylococcus aureus, 1.0μg/mL for S. intermedius, >512.0μg/mL for coagulase negative Staphylococcus, and 256.0μg/mL for Gram-negative rods. In addition, it was investigated the possible cross-resistance between oxacillin and azithromycin, by detection of mecA gen in Staphylococcus spp. Nine (15 percent) mecA-positive Staphylococcus spp. were also phenotypically resistant to azithromycin.(AU)

Minimal inhibitory concentration of azithromycin in Rhodococcus equi strains isolated from foals / Concentração inibitória mínima da azitromicina em linhagens de Rhodococcus equi isoladas de potros

O perfil de sensibilidade microbiana e a concentração inibitória mínima (MIC) da azitromicina para 42 cepas de Rhodococcus equi isoladas de potros, no Brasil, e em uma cepa-controle, foi avaliado, respectivamente, pelos métodos de difusão com discos e E-test. A azitromicina apresentou 100% de efetividade in vitro para todas as cepas em ambos os testes. As cepas de R. equi apresentaram MIC90 para azitromicina em valores <1.5µg/ml. Este estudo mostra a alta efetividade da azitromicina em linhagens de R. equi isoladas no Brasil, sugerindo o uso dessa droga como alternativa na terapia da rodococose em potros.(AU)